Evidence for altered Wnt signaling in psoriatic skin.

[1]  Xing Li,et al.  Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. , 2009, The Journal of investigative dermatology.

[2]  R. Dahiya,et al.  Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. , 2009, Cancer research.

[3]  S. Bray,et al.  Wnt5a Exhibits Layer-Specific Expression in Adult Skin, Is Upregulated in Psoriasis, and Synergizes with Type 1 Interferon , 2009, PloS one.

[4]  James T. Elder,et al.  Lack of evidence for activation of the hedgehog pathway in psoriasis. , 2009, The Journal of investigative dermatology.

[5]  Pui-Yan Kwok,et al.  Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.

[6]  G. Ghosh,et al.  Transcriptional Outcome of Wnt-Frizzled Signal Transduction in Inflammation: Evolving Concepts , 2008, The Journal of Immunology.

[7]  R. Nusse,et al.  Alternative Wnt Signaling Is Initiated by Distinct Receptors , 2008, Science Signaling.

[8]  L. Kemény,et al.  Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. , 2008, The Journal of investigative dermatology.

[9]  R. Ralhan,et al.  Wnt Signaling Pathway in Invasive Ductal Carcinoma of the Breast: Relationship between β-Catenin, Disheveled and Cyclin D1 Expression , 2008, Oncology.

[10]  D. Charnock-Jones,et al.  Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. , 2008, Biochemical and biophysical research communications.

[11]  Lisa C. Zaba,et al.  Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2007, The Journal of experimental medicine.

[12]  N. Reynolds,et al.  Increased nuclear β‐catenin in suprabasal involved psoriatic epidermis , 2007 .

[13]  M. Katoh,et al.  WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.

[14]  P. Mortimer,et al.  In vivo quantification of microvessels in clinically uninvolved psoriatic skin and in normal skin , 2007, The British journal of dermatology.

[15]  James T. Elder,et al.  Mouse models of psoriasis. , 2007, The Journal of investigative dermatology.

[16]  Mayumi Ito,et al.  Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding , 2007, Nature.

[17]  Hideki Yamamoto,et al.  Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling. , 2007, The Biochemical journal.

[18]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[19]  M. Lebwohl,et al.  A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. , 2007, The New England journal of medicine.

[20]  Steven J. Schrodi,et al.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.

[21]  B. Tycko,et al.  Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. , 2006, Molecular biology of the cell.

[22]  Holger Heine,et al.  The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. , 2006, Blood.

[23]  R. Nusse,et al.  Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context , 2006, PLoS biology.

[24]  R. Dahiya,et al.  Epigenetic Inactivation of Wnt Inhibitory Factor-1 Plays an Important Role in Bladder Cancer through Aberrant Canonical Wnt/β-Catenin Signaling Pathway , 2006, Clinical Cancer Research.

[25]  Randall T. Moon,et al.  Wnt and calcium signaling: β-Catenin-independent pathways , 2005 .

[26]  A. Gottlieb,et al.  TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques1 , 2005, The Journal of Immunology.

[27]  O. Boyman,et al.  Plasmacytoid predendritic cells initiate psoriasis through interferon-α production , 2005, The Journal of experimental medicine.

[28]  S. Aaronson,et al.  The Mechanism of Endogenous Receptor Activation Functionally Distinguishes Prototype Canonical and Noncanonical Wnts , 2005, Molecular and Cellular Biology.

[29]  M. Asashima,et al.  Maternal Wnt11 Activates the Canonical Wnt Signaling Pathway Required for Axis Formation in Xenopus Embryos , 2005, Cell.

[30]  D. Voskas,et al.  A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. , 2005, The American journal of pathology.

[31]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[32]  Wange Lu,et al.  Mammalian Ryk Is a Wnt Coreceptor Required for Stimulation of Neurite Outgrowth , 2004, Cell.

[33]  A. Bennett,et al.  Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab , 2004, The British journal of dermatology.

[34]  A. Gottlieb,et al.  Etanercept as monotherapy in patients with psoriasis. , 2003, The New England journal of medicine.

[35]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[36]  Nobuyuki Onishi,et al.  The receptor tyrosine kinase Ror2 is involved in non‐canonical Wnt5a/JNK signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[37]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[38]  R. Moon,et al.  Signaling of Rat Frizzled-2 Through Phosphodiesterase and Cyclic GMP , 2002, Science.

[39]  Choun-Ki Joo,et al.  Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.

[40]  M. Lebwohl,et al.  Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. , 2001, The Journal of investigative dermatology.

[41]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[42]  R. Moon,et al.  The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. , 2000, Trends in genetics : TIG.

[43]  J. Nathans,et al.  A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.

[44]  James T. Elder,et al.  Retinoid regulation of heparin‐binding EGF‐like growth factor gene expression in human keratinocytes and skin * , 1998, Experimental dermatology.

[45]  M. Oshimura,et al.  Ectopic Expression of wnt-5a in Human Renal Cell Carcinoma Cells Suppresses in vitro Growth and Telomerase Activity , 1998, Tumor Biology.

[46]  R. Moon,et al.  Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling , 1997, Nature.

[47]  P. Libby,et al.  Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. , 1997, Journal of immunology.

[48]  J. Nathans,et al.  A Member of the Frizzled Protein Family Mediating Axis Induction by Wnt-5A , 1997, Science.

[49]  Irene M. Leigh,et al.  Keratins (Kl6 and Kl7) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro , 1995 .

[50]  I. Jónsdóttir,et al.  Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? , 1995, Immunology today.

[51]  H. Dvorak,et al.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.

[52]  M. Yamamura,et al.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.

[53]  F. Watt,et al.  Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. , 1992, The Journal of clinical investigation.

[54]  R. Coffey,et al.  Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. , 1992, Cancer research.

[55]  J. Laborda,et al.  36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. , 1991, Nucleic acids research.

[56]  James T. Elder,et al.  Overexpression of transforming growth factor alpha in psoriatic epidermis. , 1989, Science.

[57]  G. Weinstein,et al.  Cell kinetic basis for pathophysiology of psoriasis. , 1985, The Journal of investigative dermatology.

[58]  E. Lane,et al.  Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation , 1985, The British journal of dermatology.

[59]  J. Mansbridge,et al.  Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis. , 1984, The Journal of investigative dermatology.

[60]  B. Thiers.  A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes , 2008 .

[61]  Joachim Reischl,et al.  Increased expression of Wnt5a in psoriatic plaques. , 2007, The Journal of investigative dermatology.

[62]  N. Reynolds,et al.  Increased nuclear beta-catenin in suprabasal involved psoriatic epidermis. , 2007, The British journal of dermatology.

[63]  Randall T Moon,et al.  Wnt and calcium signaling: beta-catenin-independent pathways. , 2005, Cell calcium.

[64]  山崎 文恵.  Immunohistochemical detection for nuclear β-catenin in sporadic basal cell carcinoma , 2002 .

[65]  James T. Elder,et al.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. , 2001, Neoplasia.

[66]  I. Leigh,et al.  Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. , 1995, The British journal of dermatology.

[67]  N. Wright,et al.  Psoriasis, cell proliferation , 1983 .